Effect of breast-feeding frequency on hyperbilirubinemia in breast-fed term neonate

Ying-Juang Chen1, Tsu-Fu Yeh2, Chung-Ming Chen1,2,3

  • 1Department of Pediatrics, Taipei Medical University Hospital.

Insights

Frequent breastfeeding, encouraged through nursery discharge instructions, significantly reduces hyperbilirubinemia in newborns. This practice also supports healthy infant bodyweight gain.

Area of Science:

  • Neonatal Medicine
  • Pediatrics
  • Public Health

Background:

  • Hyperbilirubinemia is common in newborns, often associated with reduced bodyweight gain post-discharge.
  • Early identification and intervention are crucial for managing neonatal jaundice.

Purpose of the Study:

  • To investigate if nursery discharge instructions promoting frequent breastfeeding impact infant bodyweight gain.
  • To determine the effect of enhanced breastfeeding guidance on hyperbilirubinemia incidence.

Main Methods:

  • A cohort of 98 term neonates receiving outpatient follow-up within two weeks of birth were studied.
  • Parents recorded breastfeeding and diaper change frequency post-discharge.
  • Neonates were grouped based on breastfeeding frequency (≥8 times/day vs. <8 times/day).

Main Results:

  • Breastfeeding frequency strongly correlated with diaper change frequency, indicating data reliability.
  • No significant differences in gestational age, Apgar scores, or birthweights were observed between groups.
  • Neonates breastfed 8 or more times daily showed a significantly lower incidence of hyperbilirubinemia.

Conclusions:

  • Nursery discharge instructions emphasizing frequent breastfeeding are effective in reducing hyperbilirubinemia rates.
  • This intervention supports healthy outcomes for exclusively breastfed term neonates.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
354
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
499
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
829
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
44
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
389
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
886